Abstract
Currently, the stroke is registered amongst the five leading causes of death and disability worldwide. From the European perspective approximately 1.1 million individuals become stroke diagnosed each year. The disorder demonstrates severe socioeconomic consequences: the associated total EU costs are as high as €45 billion annually.
Even if the majority of the stroke cases are diagnosed in the elderly, about 10% of all patients experience the disorder at the age below 50 years – so-called “young strokes”. Moreover, the incidence as well prevalence of stroke in young adults is dramatically increasing worldwide. Further, the proportion of strokes with unknown etiology among the youngest subgroup of patients reaches up to 39.6–42% that remains largely unexplained. Therefore, specifically modifiable risk factors such as suboptimal heath conditions are proposed to be considered for innovative risk assessment in the “young stroke” prediction and prevention.
Due to symptoms characteristic for the Flammer syndrome (FS), we hypothesised a potential relationship between FS phenotype and increased risks for the “young stroke” predisposition. FS characteristic symptoms and signs analysed in the chapter may further synergistically contribute to the cerebrovascular events being potentially indicative for the stroke predisposition in young individuals.
If the hypothesised association become confirmed by multi-centre studies run, FS phenotype may get of great clinical utility for creating innovative strategies of predictive, preventive and personalised medicine for the stroke management utilising novel screening programmes, individualised patient profiling, specialised questionnaires and novel biomarker patterns for an effective risk assessment, targeted prevention, and therapy monitoring tailored to the person.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnston SC, Mendis S, Mathers CD (2009) Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol 8:345–354
Béjot Y, Bailly H, Durier J, Giroud M (2016) Epidemiology of stroke in Europe and trends for the 21st century. Presse Med 45:e391–e398
Polivka J, Polivka J, Rohan V (2018) Predictive and individualized management of stroke—success story in Czech Republic. EPMA J [Internet]. [cited 2018 Nov 26]. Available from: https://doi.org/10.1007/s13167-018-0150-x
Maaijwee NAMM, Rutten-Jacobs LCA, Schaapsmeerders P, van Dijk EJ, de Leeuw F-E (2014) Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol 10:315–325
Béjot Y, Delpont B, Giroud M (2016) Rising stroke incidence in young adults: more epidemiological evidence, more questions to be answered. J Am Heart Assoc 5
Aigner A, Grittner U, Rolfs A, Norrving B, Siegerink B, Busch MA (2017) Contribution of established stroke risk factors to the burden of stroke in young adults. Stroke 48:1744–1751
von Sarnowski B, Putaala J, Grittner U, Gaertner B, Schminke U, Curtze S et al (2013) Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study. Stroke 44:119–125
Goeggel Simonetti B, Mono M-L, Huynh-Do U, Michel P, Odier C, Sztajzel R et al (2015) Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS). J Neurol 262:2025–2032
Tatlisumak T, Cucchiara B, Kuroda S, Kasner SE, Putaala J (2018) Nontraumatic intracerebral haemorrhage in young adults. Nat Rev Neurol 14:237–250
Ji R, Schwamm LH, Pervez MA, Singhal AB (2013) Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis. JAMA Neurol 70:51–57
Kwon SU, Kim JS, Lee JH, Lee MC (2000) Ischemic stroke in Korean young adults. Acta Neurol Scand 101:19–24
de los Ríos F, Kleindorfer DO, Khoury J, Broderick JP, Moomaw CJ, Adeoye O et al (2012) Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke 43:3179–3183
Yesilot Barlas N, Putaala J, Waje-Andreassen U, Vassilopoulou S, Nardi K, Odier C et al (2013) Etiology of first-ever ischaemic stroke in European young adults: the 15 cities young stroke study. Eur J Neurol 20:1431–1439
Mallick AA, Ganesan V, Kirkham FJ, Fallon P, Hedderly T, McShane T et al (2014) Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study. Lancet Neurol 13:35–43
Gerstl L, Weinberger R, von Kries R, Heinen F, Schroeder AS, Bonfert MV et al (2018) Risk factors in childhood arterial ischaemic stroke: findings from a population-based study in Germany. Eur J Paediatr Neurol 22:380–386
Riel-Romero RMS, Kalra AA, Gonzalez-Toledo E (2009) Childhood and teenage stroke. Neurol Res 31:775–784
Riel-Romero RMS (2008) Neonatal stroke. Neurol Res 30:839–844
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
Schneider S, Kornejeva A, Vibo R, Kõrv J (2017) Risk factors and etiology of young ischemic stroke patients in Estonia. Stroke Res Treat 2017:8075697
Ferro JM, Massaro AR, Mas J-L (2010) Aetiological diagnosis of ischaemic stroke in young adults. Lancet Neurol 9:1085–1096
Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8:200
Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Wijnhoven TMA, van Raaij JMA, Spinelli A, Rito AI, Hovengen R, Kunesova M et al (2013) WHO European Childhood Obesity Surveillance Initiative 2008: weight, height and body mass index in 6-9-year-old children. Pediatr Obes 8:79–97
O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H et al (2016) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388:761–775
Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A et al (2014) Flammer syndrome. EPMA J 5:11
Flammer Syndrome [Internet]. [cited 2018 Jul 12]. Available from: http://www.flammer-syndrome.ch/index.php?id=32
Flammer J, Konieczka K (2017) The discovery of the Flammer syndrome: a historical and personal perspective. EPMA J 8:75–97
Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J (2016) Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). EPMA J 7:13
Smokovski I, Risteski M, Polivka J, Zubor P, Konieczka K, Costigliola V et al (2017) Postmenopausal breast cancer: European challenge and innovative concepts. EPMA J 8:159–169
Zubor P, Gondova A, Polivka J, Kasajova P, Konieczka K, Danko J et al (2017) Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J 8:129–140
Bubnov R, Polivka J, Zubor P, Konieczka K, Golubnitschaja O (2017) “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset? “Flammer Syndrome” relevance to address the question. EPMA J 8:141–157
Polivka J, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O (2017) Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J 8:119–127
Kunin A, Polivka J, Moiseeva N, Golubnitschaja O (2018) “Dry mouth” and “Flammer” syndromes-neglected risks in adolescents and new concepts by predictive, preventive and personalised approach. EPMA J 9:307–317
Barthelmes J, Nägele MP, Ludovici V, Ruschitzka F, Sudano I, Flammer AJ (2017) Endothelial dysfunction in cardiovascular disease and Flammer syndrome-similarities and differences. EPMA J 8:99–109
Gugleta K, Zawinka C, Rickenbacher I, Kochkorov A, Katamay R, Flammer J et al (2006) Analysis of retinal vasodilation after flicker light stimulation in relation to vasospastic propensity. Invest Ophthalmol Vis Sci 47:4034–4041
Donnelly J, Budohoski KP, Smielewski P, Czosnyka M (2016) Regulation of the cerebral circulation: bedside assessment and clinical implications. Crit Care 20:129
Golubnitschaja O (2017) Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J 8:17–22
Flammer J, Konieczka K, Flammer AJ (2013) The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J 4:14
Konieczka K, Erb C (2017) Diseases potentially related to Flammer syndrome. EPMA J 8:327–332
Wesselink EM, Kappen TH, Torn HM, Slooter AJC, van Klei WA (2018) Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review. Br J Anaesth 121:706–721
Golubnitschaja O, Flammer J (2018) Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine. EPMA J 9:15–20
Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C (2018) Estrogen, migraine, and vascular risk. Neurol Sci 39:11–20
Fridman S, Sposato LA (2018) Migraine with visual aura, incident AF, and stroke risk: is migraine with aura an embolic TIA? Neurology 91:1077–1078
Sen S, Androulakis XM, Duda V, Alonso A, Chen LY, Soliman EZ et al (2018) Migraine with visual aura is a risk factor for incident atrial fibrillation: a cohort study. Neurology 91:e2202–e2210
Sadrameli SS, Gadhia RR, Kabir R, Volpi JJ (2018) Patent foramen ovale in cryptogenic stroke and migraine with aura: does size matter? Cureus 10:e3213
Zhang DP, Li HR, Ma QK, Yin S, Peng YF, Zhang HL et al (2018) Prevalence of stroke and hypoperfusion in patients with isolated vertigo and vascular risk factors. Front Neurol 9:974
Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A et al (2014) Flammer syndrome. EPMA J 5:11
Huang Y-S, Koo M, Chen J-C, Hwang J-H (2017) The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: a secondary case-control analysis of a nationwide, population-based health claims database. PLoS One 12:e0187474
Dehkharghani S, Fleischer CC, Qiu D, Yepes M, Tong F (2017) Cerebral temperature dysregulation: MR thermographic monitoring in a nonhuman primate study of acute ischemic stroke. AJNR Am J Neuroradiol 38:712–720
Bahouth MN, Hillis A, Gottesman R (2015) Abstract T MP86: a prospective study of the effect of dehydration on stroke severity and short term outcome. Stroke 46:ATMP86
Yong WC, Sanguankeo A, Upala S (2018) Association between primary Sjögren’s syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis. Clin Exp Rheumatol 36(Suppl 112):190–197
Yang D, Qiao L, Zhao LD (2016) Cerebral infarction in a patient with primary Sjogren’s syndrome: a case report and literature review. Beijing Da Xue Xue Bao 48:1077–1080
Baban B, Golubnitschaja O (2017) The potential relationship between Flammer and Sjögren syndromes: the chime of dysfunction. EPMA J 8:333–338
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L (2018) Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol 6:944–953
Pache M, Kräuchi K, Cajochen C, Wirz-Justice A, Dubler B, Flammer J et al (2001) Cold feet and prolonged sleep-onset latency in vasospastic syndrome. Lancet 358:125–126
Duss SB, Brill A-K, Bargiotas P, Facchin L, Alexiev F, Manconi M et al (2018) Sleep-wake disorders in stroke-increased stroke risk and deteriorated recovery? An evaluation on the necessity for prevention and treatment. Curr Neurol Neurosci Rep 18:72
Sabel BA, Wang J, Cárdenas-Morales L, Faiq M, Heim C (2018) Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine. EPMA J 9:133–160
Yeghiazaryan K, Flammer J, Golubnitschaja O (2010) Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 1:263–272
Golubnitschaja O, Yeghiazaryan K, Flammer J (2019) Multiomic signature of glaucoma predisposition in Flammer syndrome affected individuals – innovative PPPM strategies in disease management. Flammer Syndrome and Associated Pathologies. Springer
Handforth A, Parker GA (2018) Conditions associated with essential tremor in veterans: a potential role for chronic stress. Tremor Other Hyperkinet Mov (NY) 8:517
Gowey MA, Khodneva Y, Tison SE, Carson AP, Cherrington AL, Howard VJ et al (2019) Depressive symptoms, perceived stress, and metabolic health: the REGARDS study. Int J Obes 43:615–632
Leung LY, Caplan LR (2016) Factors associated with delay in presentation to the Hospital for Young Adults with ischemic stroke. Cerebrovasc Dis 42:10–14
Polivka J, Krakorova K, Peterka M, Topolcan O (2016) Current status of biomarker research in neurology. EPMA J 7:14
Polívka J, Rohan V, Sevčík P, Polívka J (2014) Personalized approach to primary and secondary prevention of ischemic stroke. EPMA J 5:9
Rutten-Jacobs LCA, Maaijwee NAM, Arntz RM, Schoonderwaldt HC, Dorresteijn LD, van der Vlugt MJ et al (2013) Long-term risk of recurrent vascular events after young stroke: the FUTURE study. Ann Neurol 74:592–601
Putaala J, Haapaniemi E, Kaste M, Tatlisumak T (2012) How does number of risk factors affect prognosis in young patients with ischemic stroke? Stroke 43:356–361
Li F, Yang L, Yang R, Xu W, Chen F-P, Li N et al (2017) Ischemic stroke in young adults of Northern China: characteristics and risk factors for recurrence. Eur Neurol 77:115–122
Renna R, Pilato F, Profice P, Della Marca G, Broccolini A, Morosetti R et al (2014) Risk factor and etiology analysis of ischemic stroke in young adult patients. J Stroke Cerebrovasc Dis 23:e221–e227
Sarfo FS, Ovbiagele B, Gebregziabher M, Wahab K, Akinyemi R, Akpalu A et al (2018) Stroke among young West Africans: evidence from the SIREN (Stroke Investigative Research and Educational Network) large multisite case-control study. Stroke 49:1116–1122
Montanaro VVA, Freitas DDS, Ruiz MCM, Cavalcanti EBU, Marinho PBC, Freitas MCDNB et al (2017) Ischemic stroke in young adults: profile of SARAH Hospital Brasília from 2008 to 2012. Neurologist 22:61–63
Mitchell AB, Cole JW, McArdle PF, Cheng Y-C, Ryan KA, Sparks MJ et al (2015) Obesity increases risk of ischemic stroke in young adults. Stroke 46:1690–1692
Park D, Lee J-H, Han S (2017) Underweight: another risk factor for cardiovascular disease?: a cross-sectional 2013 Behavioral Risk Factor Surveillance System (BRFSS) study of 491,773 individuals in the USA. Medicine (Baltimore) 96:e8769
Cui R, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S et al (2005) Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study. Stroke 36:1377–1382
Markidan J, Cole JW, Cronin CA, Merino JG, Phipps MS, Wozniak MA et al (2018) Smoking and risk of ischemic stroke in young men. Stroke 49:1276–1278
Bhat VM, Cole JW, Sorkin JD, Wozniak MA, Malarcher AM, Giles WH et al (2008) Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke 39:2439–2443
Magee CA, Kritharides L, Attia J, McElduff P, Banks E (2012) Short and long sleep duration are associated with prevalent cardiovascular disease in Australian adults. J Sleep Res 21:441–447
Sloan MA, Kittner SJ, Feeser BR, Gardner J, Epstein A, Wozniak MA et al (1998) Illicit drug-associated ischemic stroke in the Baltimore-Washington Young Stroke Study. Neurology 50:1688–1693
Wolff V, Lauer V, Rouyer O, Sellal F, Meyer N, Raul JS et al (2011) Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 42:1778–1780
Westover AN, McBride S, Haley RW (2007) Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry 64:495–502
Roach REJ, Helmerhorst FM, Lijfering WM, Stijnen T, Algra A, Dekkers OM (2015) Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev 8:CD011054
Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M (2013) Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab 27:35–45
Ban L, Sprigg N, Abdul Sultan A, Nelson-Piercy C, Bath PM, Ludvigsson JF et al (2017) Incidence of first stroke in pregnant and nonpregnant women of childbearing age: a population-based cohort study from England. J Am Heart Assoc 6(4). pii: e004601.
Maino A, Siegerink B, Algra A, Martinelli I, Peyvandi F, Rosendaal FR (2016) Pregnancy loss and risk of ischaemic stroke and myocardial infarction. Br J Haematol 174:302–309
González-Gómez FJ, Pérez-Torre P, DeFelipe A, Vera R, Matute C, Cruz-Culebras A et al (2016) Stroke in young adults: incidence rate, risk factors, treatment and prognosis. Rev Clin Esp 216:345–351
Lightbody CE, Clegg A, Patel K, Lucas JC, Storey H, Hackett ML et al (2017) Systematic review and meta-analysis of psychosocial risk factors for stroke. Semin Neurol 37:294–306
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Polivka, J. et al. (2019). “Young Stroke” Risks Potentially Linked to the Flammer Syndrome Phenotype: Facts and Hypotheses. In: Golubnitschaja, O. (eds) Flammer Syndrome. Advances in Predictive, Preventive and Personalised Medicine, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-030-13550-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-13550-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-13549-2
Online ISBN: 978-3-030-13550-8
eBook Packages: MedicineMedicine (R0)